FDA has approved the use of Boston Scientific's STIMVIEW XT software. The technology allows you to build 3D models to monitor the brain when treating Parkinson's disease or essential tremor with electrodes. With STIMVIEW XT, electrode placement time is reduced by 56% to about 20 minutes.
FDA has approved the use of Boston Scientific's STIMVIEW XT software. The technology allows you to build 3D models to monitor the brain when treating Parkinson's disease or essential tremor with electrodes. With STIMVIEW XT, electrode placement time is reduced by 56% to about 20 minutes. 
English (US) 